The people who work for the pharmaceutical organizations in the Johnson & Johnson Family of Companies are focused on scientific innovation in health care. You might say it is our reason for being. But we recognize that innovation is not limited to our own scientists, technology experts and marketers. We are strongly committed to partnering with like-minded individuals and companies whose innovative thinking and knowledge have the potential to move the field of medicine forward. We believe together we can improve health care for generations to come while achieving our common business goals.

The pharmaceutical businesses within Johnson & Johnson are broad in scope, with strength in diverse research platforms. During 2003, Johnson & Johnson committed nearly $4 billion to research and development, and our efforts likely will grow in the years ahead. We have expertise in small and large molecules, genomics and bioinformatics, and drug delivery technology, among other promising areas. We believe in the promise of better health care and the exceptional business results that partnering offers.